How much GLP-1 weight loss medications cost without insurance in 2026
Paying cash, a branded GLP-1 now usually runs about $149 to $449 a month through manufacturer programs, or over $1,000 at list price. Here is where those numbers come from and what moves them.
Without insurance, a month of a branded GLP-1 for weight management now usually costs somewhere between about $149 and $449 if you buy through the manufacturer's self-pay programs, and well over $1,000 if you pay the list price at a pharmacy counter. Which end of that range you land on depends on the drug, the dose, the form it comes in and where you fill it.
The short version
- List prices are not what most cash-paying patients pay anymore. Wegovy's list price is about $1,349 per four-week package; Zepbound's is roughly $1,086.
- Novo Nordisk (through NovoCare) and Eli Lilly (through LillyDirect) sell their weight-management drugs directly to self-paying patients at much lower prices, with a valid prescription.
- When we checked in November 2026, Wegovy injection was $349 a month at most doses, the Wegovy pill started at $149, and Zepbound started at $299.
- Manufacturer copay cards that bring the price down to around $25 only work with commercial insurance. They do not lower the cash price.
- The medication is only part of the bill. Clinician visits, lab work and any program fees are separate, and those vary by practice.
Every figure in this article was checked against manufacturer pages or reporting from November 2026. These prices have changed several times in the past two years and will change again, so treat them as a starting point and confirm before you fill a prescription. If you are still deciding which medication fits, our semaglutide vs tirzepatide comparison covers the clinical side.
List price versus what people actually pay
The list price, sometimes called the wholesale acquisition cost, is the figure the manufacturer sets before any discounts, rebates or insurance negotiations. It is the number you see in news headlines, and it is the number a retail pharmacy may charge if you walk in with a prescription and no coverage and no savings program.
For Wegovy, that list price has been about $1,349 per package, which is a four-week supply. Novo Nordisk said in February 2026 that it plans to cut the Wegovy list price to $675 a month starting January 1, 2027. Zepbound's list price has been reported at roughly $1,086 a month. Few cash-paying patients pay these amounts today, because both manufacturers now run direct self-pay programs that sit outside insurance.
Branded self-pay prices, November 2026
Wegovy (semaglutide) through NovoCare
According to NovoCare's own pricing page in November 2026:
- Wegovy injection was $349 a month for the 0.25 mg through 2.4 mg doses. New patients could get their first two monthly fills of the 0.25 mg and 0.5 mg starting doses for $199 each, an offer the page said runs through December 31, 2026.
- Wegovy HD, the 7.2 mg dose the FDA approved in March 2026, was $399 a month.
- Wegovy pill (oral semaglutide) was $149 a month for the 1.5 mg starting dose, $199 for 4 mg, and $299 for the 9 mg and 25 mg doses.
A "month" here means one box of four pens or one bottle of 30 tablets. NovoCare states that pricing will be updated after December 31, 2026, and that the program can change at any time.
Zepbound and Foundayo through LillyDirect
Lilly's LillyDirect pharmacy listed Zepbound at $299 a month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg through 15 mg, with that top tier depending on refilling within 45 days of your previous fill. Lilly said in March 2026 that the multi-dose KwikPen and the single-dose vials carry the same self-pay price at each dose. Some third-party sites report higher prices for people who miss the refill window; check Lilly's current terms if your schedule is irregular.
Foundayo (orforglipron), the daily GLP-1 pill the FDA approved in April 2026, is also sold through LillyDirect. Its self-pay price starts at $149 for the lowest dose. Reports of the price at higher doses conflicted when we checked, so confirm it with Lilly directly.
Worth knowing
TrumpRx, a federal website launched in 2026, lists the same manufacturer cash prices and links out to them. It does not usually offer a lower price than buying from the manufacturer directly. It is a directory, not a pharmacy.
What about copay cards and coupons?
Both manufacturers offer savings cards that can bring the cost down to as little as $25 a month. These are generally for people with commercial insurance, and the lowest prices usually require that the plan covers the drug. Terms differ by program and change often. They are not available to people on Medicare, Medicaid or other government plans, and they do not reduce the price for someone paying cash with no insurance at all.
Pharmacy discount cards and coupon sites can sometimes beat the list price at a retail counter, but for these particular drugs they rarely beat the manufacturers' own self-pay prices. It is worth comparing, but don't expect a large difference.
Self-pay purchases also do not count toward your insurance deductible or out-of-pocket maximum. If you have insurance that might cover the drug after a prior authorization, it may be worth trying that route first. Our article on whether insurance covers weight loss medication walks through how that works.
Compounded GLP-1s and their price
Compounded semaglutide and tirzepatide are often advertised at prices well below the branded self-pay programs. They are not FDA-approved, they are not generics, and the FDA has not reviewed them for safety, effectiveness or manufacturing quality. The large-scale compounding market grew while both drugs were on the FDA shortage list; both shortages have since been declared resolved.
In 2026 the FDA stepped up enforcement. It announced in February that it intended to restrict GLP-1 active ingredients used in non-approved compounded drugs, and it sent dozens of warning letters to telehealth companies in March and June over marketing claims. We don't quote compounded prices here because they vary widely and because price shouldn't be the deciding factor in that choice. Our article on what to know about compounded GLP-1s covers the trade-offs in detail.
Be careful here
A price that looks far too low for semaglutide or tirzepatide, especially one sold without a prescription or labeled "for research use only," is a warning sign. Counterfeit Ozempic has turned up in the US supply chain, and the FDA has warned about it more than once.
What drives the price you pay
- The drug. Semaglutide, tirzepatide and orforglipron are sold at different price points.
- The dose. Lilly's tiered pricing means Zepbound costs more as the dose rises. NovoCare's Wegovy injection price is flat across most doses, but the 7.2 mg dose costs more.
- The form. Pills, pens and vials can be priced differently. Daily pills have generally started at lower prices than weekly injections.
- Where you fill. The manufacturer's self-pay price usually requires filling through their pharmacy or a participating retail pharmacy with their savings offer. A regular pharmacy without the program may charge closer to list.
- Timing. Refill windows and introductory offers can change your monthly cost.
- Everything around the drug. A prescription requires a clinical evaluation, and most patients need lab work and follow-up visits, especially during dose increases. Those costs come from the practice and the lab, not the manufacturer.
Thinking about the full year
These medications are generally prescribed as long-term treatment. Trials such as STEP-4 and SURMOUNT-4 found that many people regained weight after stopping, which is covered in our piece on what happens when you stop a GLP-1. A monthly price that feels manageable for three months may feel different over two years. It is reasonable to budget for the long run before starting, and to ask any prescriber what the full cost of care looks like, including visits and labs.
You may be able to use a health savings account or flexible spending account for prescribed medication and clinical visits; our guide to HSA and FSA use for telehealth explains the general rules.
If you want to know whether a GLP-1 is appropriate for you and which option fits your budget, a clinician can go through both questions together. Our weight management service page explains how the program works and what it costs. A clinician may also conclude that a GLP-1 isn't the right choice for you.
Questions patients ask us
How much does Wegovy cost without insurance?
When we checked NovoCare in November 2026, Wegovy injection was $349 a month for the 0.25 mg through 2.4 mg doses, with a $199 introductory price for the first two fills of the starting doses through December 31, 2026. The 7.2 mg dose was $399. Prices change, so confirm before filling.
How much does Zepbound cost without insurance?
LillyDirect listed Zepbound at $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 mg through 15 mg in November 2026, with the top tier depending on refilling within 45 days. Lilly said vials and the KwikPen are priced the same at each dose. Confirm current terms with Lilly.
How much does the Wegovy pill cost without insurance?
NovoCare listed the Wegovy pill in November 2026 at $149 a month for the 1.5 mg starting dose, $199 for 4 mg, and $299 for 9 mg and 25 mg. A month is one bottle of 30 tablets. Novo Nordisk says pricing will be updated after December 31, 2026.
How much does Foundayo cost without insurance?
Foundayo, Lilly's daily GLP-1 pill approved in April 2026, starts at $149 a month for the lowest dose through LillyDirect. Reported prices for higher doses conflicted when we checked in November 2026, so confirm the price for your dose directly with Lilly before relying on any figure.
What is the list price of Wegovy and Zepbound?
Wegovy's list price has been about $1,349 per four-week package, and Zepbound's has been reported at roughly $1,086 a month. Novo Nordisk said in February 2026 it plans to cut Wegovy's list price to $675 starting January 2027. Most cash-paying patients now use the lower self-pay programs instead.
Can I use a GLP-1 savings card if I do not have insurance?
Generally, no. Manufacturer savings cards that bring the cost to around $25 a month are designed for people with commercial insurance, and they cannot be used with Medicare, Medicaid or other government plans. Uninsured patients usually get the lowest price through the manufacturer's self-pay program instead.
Is TrumpRx cheaper than buying GLP-1s directly?
Usually not. TrumpRx is a federal website that lists manufacturer cash prices and links to them. It works as a directory rather than a pharmacy, and the prices shown generally match what NovoCare and LillyDirect offer. It can be a useful place to compare, but check the manufacturer's own terms too.
Why is compounded semaglutide cheaper?
Compounded semaglutide is not FDA-approved and has not gone through the trials, manufacturing validation and oversight that approved products carry. That is a large part of the price difference. The FDA has warned about compounded GLP-1 quality and marketing and said in 2026 it would act to restrict their ingredients.
Does self-pay for a GLP-1 count toward my deductible?
No. Buying through a manufacturer self-pay program happens outside your insurance, so it generally does not count toward your deductible or out-of-pocket maximum and cannot be submitted as a claim. If your plan might cover the drug with prior authorization, it may be worth trying that route first.
What costs are there besides the medication itself?
A prescription requires a clinical evaluation, and most people need follow-up visits, especially during dose increases, plus lab work. Those fees come from the practice and the lab, not the manufacturer, and vary widely. Ask any provider for the full cost of care. HSA or FSA funds may cover some of it.
Talk to a licensed clinician
Reading about a treatment is not the same as knowing whether it fits your history. A consultation is a conversation about your own situation — not a sales call, and not a promise of any outcome.
